These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1728 related items for PubMed ID: 9828245

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M, Lämmle B.
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM, Lian EC.
    N Engl J Med; 1998 Nov 26; 339(22):1585-94. PubMed ID: 9828246
    [Abstract] [Full Text] [Related]

  • 4. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE, Turecek PL, Schwarz HP, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Nov 26; 82(5):1386-9. PubMed ID: 10595623
    [Abstract] [Full Text] [Related]

  • 5. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M.
    Expert Rev Cardiovasc Ther; 2003 Jul 26; 1(2):243-55. PubMed ID: 15030284
    [Abstract] [Full Text] [Related]

  • 6. Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.
    Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y.
    Transfusion; 2002 May 26; 42(5):572-80. PubMed ID: 12084165
    [Abstract] [Full Text] [Related]

  • 7. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M, Lämmle B.
    Semin Thromb Hemost; 2002 Apr 26; 28(2):167-72. PubMed ID: 11992240
    [Abstract] [Full Text] [Related]

  • 8. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Solenthaler M, Wassmer M, Sandoz P, Lämmle B.
    Blood; 1997 May 01; 89(9):3097-103. PubMed ID: 9129011
    [Abstract] [Full Text] [Related]

  • 9. Two novel ADAMTS13 gene mutations in thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome (TTP/HUS).
    Licht C, Stapenhorst L, Simon T, Budde U, Schneppenheim R, Hoppe B.
    Kidney Int; 2004 Sep 01; 66(3):955-8. PubMed ID: 15327386
    [Abstract] [Full Text] [Related]

  • 10. Deficiency of von Willebrand factor-cleaving protease in familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M, Lämmle B.
    Baillieres Clin Haematol; 1998 Jun 01; 11(2):509-14. PubMed ID: 10097823
    [Abstract] [Full Text] [Related]

  • 11. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C, Gojo I, Heyman MR.
    N Engl J Med; 1999 Apr 29; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract] [Full Text] [Related]

  • 12. von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Remuzzi G, Galbusera M, Noris M, Canciani MT, Daina E, Bresin E, Contaretti S, Caprioli J, Gamba S, Ruggenenti P, Perico N, Mannucci PM, Italian Registry of Recurrent and Familial HUS/TTP. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome.
    Blood; 2002 Aug 01; 100(3):778-85. PubMed ID: 12130486
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
    Moake JL.
    Arch Pathol Lab Med; 2002 Nov 01; 126(11):1430-3. PubMed ID: 12421153
    [Abstract] [Full Text] [Related]

  • 14. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C, Dubois B, Rorive G.
    Rev Med Liege; 2002 Jan 01; 57(1):33-9. PubMed ID: 11899496
    [Abstract] [Full Text] [Related]

  • 15. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL, Jarolím P.
    Transfus Apher Sci; 2005 Apr 01; 32(2):177-84. PubMed ID: 15784452
    [Abstract] [Full Text] [Related]

  • 16. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Tsai HM, Chandler WL, Sarode R, Hoffman R, Jelacic S, Habeeb RL, Watkins SL, Wong CS, Williams GD, Tarr PI.
    Pediatr Res; 2001 May 01; 49(5):653-9. PubMed ID: 11328948
    [Abstract] [Full Text] [Related]

  • 17. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura.
    Furlan M, Robles R, Morselli B, Sandoz P, Lämmle B.
    Thromb Haemost; 1999 Jan 01; 81(1):8-13. PubMed ID: 10348715
    [Abstract] [Full Text] [Related]

  • 18. Thrombotic thrombocytopenic purpura attributable to von Willebrand factor-cleaving protease inhibitor in an 8-year-old boy.
    Robson WL, Tsai HM.
    Pediatrics; 2002 Feb 01; 109(2):322-5. PubMed ID: 11826215
    [No Abstract] [Full Text] [Related]

  • 19. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE, Moake JL, Miyata T, George JN.
    Hematology Am Soc Hematol Educ Program; 2004 Feb 01; ():407-23. PubMed ID: 15561695
    [Abstract] [Full Text] [Related]

  • 20. Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy.
    Ajzenberg N, Denis CV, Veyradier A, Girma JP, Meyer D, Baruch D.
    Thromb Haemost; 2002 May 01; 87(5):808-11. PubMed ID: 12038781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 87.